View in EDS

Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.

Saved in:
Bibliographic Details
Title: Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.
Authors: Burchard PR; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Ruffolo LI; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Ullman NA; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Dale BS; Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA., Dave YA; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Hilty BK; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Ye J; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Georger M; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Jewell R; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Miller C; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., De Las Casas L; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA., Jarolimek W; Drug Discovery, Syntara Ltd., Sydney, New South Wales, Australia., Perryman L; Drug Discovery, Syntara Ltd., Sydney, New South Wales, Australia., Byrne MM; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Loria A; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Marin C; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Chávez Villa M; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Yeh JJ; Departments of Surgery and Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina System, Chapel Hill, North Carolina, USA., Belt BA; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA., Linehan DC; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Department of Surgery, Division of Surgical Oncology, University of Rochester Medical Center, Rochester, New York, USA., Hernandez-Alejandro R; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Division of Solid Organ Transplant Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.
Source: Hepatology communications [Hepatol Commun] 2024 Aug 05; Vol. 8 (8). Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39101793
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burchard+PR%22">Burchard PR</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ruffolo+LI%22">Ruffolo LI</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ullman+NA%22">Ullman NA</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Dale+BS%22">Dale BS</searchLink>; Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.<br /><searchLink fieldCode="AU" term="%22Dave+YA%22">Dave YA</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Hilty+BK%22">Hilty BK</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ye+J%22">Ye J</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Georger+M%22">Georger M</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Jewell+R%22">Jewell R</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Miller+C%22">Miller C</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22De+Las+Casas+L%22">De Las Casas L</searchLink>; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Jarolimek+W%22">Jarolimek W</searchLink>; Drug Discovery, Syntara Ltd., Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Perryman+L%22">Perryman L</searchLink>; Drug Discovery, Syntara Ltd., Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Byrne+MM%22">Byrne MM</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Loria+A%22">Loria A</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Marin+C%22">Marin C</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Chávez+Villa+M%22">Chávez Villa M</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Yeh+JJ%22">Yeh JJ</searchLink>; Departments of Surgery and Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina System, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Belt+BA%22">Belt BA</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Linehan+DC%22">Linehan DC</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Department of Surgery, Division of Surgical Oncology, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Hernandez-Alejandro+R%22">Hernandez-Alejandro R</searchLink>; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Division of Solid Organ Transplant Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101695860%22">Hepatology communications</searchLink> [Hepatol Commun] 2024 Aug 05; Vol. 8 (8). <i>Date of Electronic Publication: </i>2024 Aug 05 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101695860 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2471-254X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222471254X%22">2471254X </searchLink><i>NLM ISO Abbreviation: </i>Hepatol Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39101793
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/HC9.0000000000000502
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burchard PR
      – PersonEntity:
          Name:
            NameFull: Ruffolo LI
      – PersonEntity:
          Name:
            NameFull: Ullman NA
      – PersonEntity:
          Name:
            NameFull: Dale BS
      – PersonEntity:
          Name:
            NameFull: Dave YA
      – PersonEntity:
          Name:
            NameFull: Hilty BK
      – PersonEntity:
          Name:
            NameFull: Ye J
      – PersonEntity:
          Name:
            NameFull: Georger M
      – PersonEntity:
          Name:
            NameFull: Jewell R
      – PersonEntity:
          Name:
            NameFull: Miller C
      – PersonEntity:
          Name:
            NameFull: De Las Casas L
      – PersonEntity:
          Name:
            NameFull: Jarolimek W
      – PersonEntity:
          Name:
            NameFull: Perryman L
      – PersonEntity:
          Name:
            NameFull: Byrne MM
      – PersonEntity:
          Name:
            NameFull: Loria A
      – PersonEntity:
          Name:
            NameFull: Marin C
      – PersonEntity:
          Name:
            NameFull: Chávez Villa M
      – PersonEntity:
          Name:
            NameFull: Yeh JJ
      – PersonEntity:
          Name:
            NameFull: Belt BA
      – PersonEntity:
          Name:
            NameFull: Linehan DC
      – PersonEntity:
          Name:
            NameFull: Hernandez-Alejandro R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 08
              Text: 2024 Aug 05
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2471-254X
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Hepatology communications
              Type: main
ResultId 1